GENFF (Genflow Biosciences) Days Payable : 0.00 (As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Genflow Biosciences Days Payable?

Genflow Biosciences's average Accounts Payable for the six months ended in Jun. 2024 was $0.44 Mil. Genflow Biosciences's Cost of Goods Sold for the six months ended in Jun. 2024 was $0.00 Mil.

The historical rank and industry rank for Genflow Biosciences's Days Payable or its related term are showing as below:

GENFF's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 122.89
* Ranked among companies with meaningful Days Payable only.

Genflow Biosciences's Days Payable stayed the same from Jun. 2023 (0.00) to Jun. 2024 (0.00).

Genflow Biosciences Days Payable Historical Data

The historical data trend for Genflow Biosciences's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genflow Biosciences Days Payable Chart

Genflow Biosciences Annual Data

Trend

Dec21

Dec22

Dec23

Days Payable

Genflow Biosciences Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Days Payable	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Genflow Biosciences's Days Payable

For the Biotechnology subindustry, Genflow Biosciences's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genflow Biosciences's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genflow Biosciences's Days Payable distribution charts can be found below:

* The bar in red indicates where Genflow Biosciences's Days Payable falls into.

Save Embed

;

Save Embed

;

Genflow Biosciences Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Genflow Biosciences's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (0.102	+	0.323)	/	2 )	/	0	*	365
=	0.2125					/	0	*	365
=	N/A

Genflow Biosciences's Days Payable for the quarter that ended in Jun. 2024 is calculated as:

	Days Payable (Q: Jun. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Jun. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2024 )	*	Days in Period
=	( (0.323	+	0.562)	/	2 )	/	0	*	365 / 2
=	0.4425					/	0	*	365 / 2
=	N/A

Genflow Biosciences Days Payable Related Terms

Thank you for viewing the detailed overview of Genflow Biosciences's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Genflow Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genflow Biosciences PLC (OTCPK:GENFF) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

GENF:UK

Address

6 Heddon Street, London, GBR, W1B 4BT

Website

https://www.genflowbio.com

Genflow Biosciences PLC is a preclinical biotechnology company focused on developing innovative biological interventions aimed at tackling the effects of aging, potentially slowing or halting the aging process and reducing the incidence of age-related diseases and thereby increasing life span. The company is also focused on longevity and the development of therapies to counteract the effects of aging and diseases associated with age.